Victims: Thalidomide sold in Spain post-withdrawal

May 8, 2013 by Jorge Sainz

(AP)—Spanish victims of thalidomide on Wednesday published documents they claim prove a German drug company kept distributing the notorious drug in Spain six months after it was taken off the market in other countries.

Gruenenthal withdrew thalidomide in 1961. It had been prescribed to pregnant women mostly to combat but led to a wave of birth defects in Europe, Australia, Canada and Japan. The company has refused to accept liability, but last year it apologized to victims and has set up a fund for German ones.

The Spanish Association of Thalidomide Victims released documents it said prove the distributor delivered thalidomide tablets to Spain until May 1962.

But Gruenenthal's vice-president for corporate affairs, Frank Schonrock, insisted in comments emailed to The Associated Press that his company pulled the drug in Spain at the same time as in Germany.

The Spanish victims intend to present the documents about the distribution of thalidomide tablets when its lawsuit against Gruenenthal begins at a Madrid court on Oct. 14, said Jose Riquelme, head of the association, which has about 200 members.

The association is asking for 208 million euros ($273 million) in compensation from the German manufacturer.

"We want to get back the dignity which the Germany pharmaceutical company took from us before we were born," Riquelme told a news conference in Madrid.

Last July, an Australian woman born without arms and legs after her mother took thalidomide reached a multimillion dollar settlement with the drug's British distributor. Gruenenthal refused to settle. The lawsuit was part of a class action, and more than 100 other survivors expect to have their claims heard this year.

is still sold today, but as a treatment for , a bone marrow cancer, and .

Explore further: German drug firm makes 1st apology for thalidomide (Update)

Related Stories

German drug firm makes 1st apology for thalidomide (Update)

August 31, 2012
(AP)—The German manufacturer of a notorious drug that caused thousands of babies to be born with shortened arms and legs, or no limbs at all, issued its first ever apology Friday—50 years after pulling the drug off the ...

Australian wins millions in Thalidomide lawsuit

July 18, 2012
(AP) — An Australian woman born without arms and legs after her pregnant mother took the anti-morning sickness drug Thalidomide has reached a multimillion dollar settlement with the medicine's British distributor, her ...

Australian woman wins thalidomide hearing: court

December 19, 2011
A woman born without arms or legs on Monday won the right to have the class action she is leading against the firms behind thalidomide, a sedative blamed for birth defects, proceed in Australia.

Thalidomide maker 'ignored birth defects for years'

July 27, 2012
The German makers of thalidomide were warned of birth defects years before it was withdrawn and Australian distributors used pregnant women as the world's first test subjects, court papers alleged Friday.

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.